Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Shares Up 0.3% – Still a Buy?

Shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) shot up 0.3% on Wednesday . The stock traded as high as $10.60 and last traded at $10.60. 1,053 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 58,164 shares. The stock had previously closed at $10.57.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

The company’s 50 day moving average price is $10.58 and its 200-day moving average price is $10.51.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Driehaus Capital Management LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth $9,180,000. Lighthouse Investment Partners LLC lifted its holdings in Oaktree Acquisition Corp. III Life Sciences by 88.9% during the second quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company’s stock valued at $8,882,000 after purchasing an additional 400,000 shares during the last quarter. Linden Advisors LP bought a new position in Oaktree Acquisition Corp. III Life Sciences during the first quarter worth about $6,120,000. Goldman Sachs Group Inc. purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the first quarter worth about $5,417,000. Finally, Moore Capital Management LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the second quarter valued at approximately $5,502,000.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.